Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XOMA | US
-0.52
-1.30%
Healthcare
Biotechnology
30/06/2024
16/04/2026
39.61
39.95
40.67
39.05
XOMA Corporation operates as a biotech royalty aggregator in Europe the United States and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville California.
View LessPositive Momentum
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
37.5%1 month
37.0%3 months
49.1%6 months
60.8%-
192.31
3.38
1.22
0.50
-6.91
32.11
-0.42
-19.10M
463.62M
463.62M
-
-9.73
37.00
568.60
-17.35
10.03
3.05
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
8.56
Range1M
14.61
Range3M
18.38
Rel. volume
0.78
Price X volume
4.20M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Adlai Nortye Ltd. | ANL | Biotechnology | 13.69 | 505.17M | 3.32% | n/a | 72.87% |
| Entrada Therapeutics Inc. Common Stock | TRDA | Biotechnology | 13.56 | 504.43M | -3.07% | 5.77 | 14.99% |
| Fulcrum Therapeutics Inc | FULC | Biotechnology | 7.99 | 498.58M | -3.15% | n/a | 3.53% |
| Valneva SE | VALN | Biotechnology | 5.97 | 484.03M | -1.00% | n/a | 126.08% |
| Aviragen Therapeutics Inc | AVIR | Biotechnology | 5.7 | 481.21M | -3.06% | n/a | 0.43% |
| Kamada Ltd | KMDA | Biotechnology | 8.24 | 473.63M | -2.37% | 20.15 | 3.41% |
| Emergent BioSolutions Inc | EBS | Biotechnology | 8.62 | 456.05M | -0.46% | n/a | 226.97% |
| REGENXBIO Inc | RGNX | Biotechnology | 9.19 | 454.20M | -1.82% | n/a | 45.57% |
| Cellectis S.A | CLLS | Biotechnology | 4.27 | 446.50M | 4.40% | n/a | 74.14% |
| Ginkgo Bioworks Holdings Inc. | DNA | Biotechnology | 7.95 | 441.82M | 2.05% | n/a | 54.29% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Malibu Boats Inc | MBUU | Recreational Vehicles | 24.73 | 494.37M | -0.12% | n/a | 1.50% |
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 22.01 | 365.53M | 0.23% | 34.27 | 26.82% |
| Camping World Holdings Inc | CWH | Recreational Vehicles | 7.27 | 328.09M | 5.98% | n/a | 3644.76% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.24 | 310.38M | 1.25% | n/a | 174.23% |
| Marine Products Corporation | MPX | Recreational Vehicles | 7.63 | 264.90M | 0.39% | 13.23 | 0.00% |
| Urban One Inc | UONEK | Broadcasting - Radio | 4.87 | 258.15M | 0.00% | n/a | 268.43% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 17.89 | 199.61M | 1.02% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 9.74 | 156.39M | 0.72% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.99 | 100.48M | 0.63% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.12 | 99.69M | 0.49% | 9.09 | 39.79% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -6.91 | 0.53 | Cheaper |
| Ent. to Revenue | 32.11 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.38 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 49.08 | 72.80 | Lower Risk |
| Debt to Equity | 1.22 | -1.23 | Expensive |
| Debt to Assets | 0.50 | 0.25 | Expensive |
| Market Cap | 463.62M | 3.66B | Emerging |